Hospital
Hallmark Health
Hallmark Health was paid $902K by Medicaid between Apr 2019 and May 2020, across 90 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.
33Billing provider infoHALLMARK HEALTH
MEDFORD, MA 02155
MEDFORD, MA 02155
33aNPI1700926169assigned 02/07/2007
33bProvider typeRehabilitation Hospital Unit
28Total paid$902K
24GClaims17,829
24DCodes billed90
24AFirst – last monthApr 2019 – May 2020
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 12,462 | $653K | |
| 2020 | 5,367 | $249K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 883 | 845 | $164K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14% | 569 | 540 | $125K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 713 | 659 | $116K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 477 | 465 | $97K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.0% | 107 | 104 | $54K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.7% | 236 | 231 | $33K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.5% | 185 | 174 | $32K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.3% | 162 | 161 | $30K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.3% | 127 | 127 | $21K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.8% | 461 | 456 | $17K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.7% | 314 | 282 | $16K |
| 59025 | Fetal non-stress test | 1.7% | 64 | 32 | $15K |
78 more codes
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.6% | 72 | $15K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.4% | 445 | $13K |
| 80053 | Comprehensive metabolic panel | 1.2% | 1,016 | $11K |
| 76830 | Ultrasound, transvaginal | 1.1% | 68 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 1,257 | $9K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 105 | $8K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 59 | $8K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 189 | $7K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 54 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 488 | $6K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 376 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 664 | $5K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 146 | $5K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 30 | $4K |
| 84702 | <1% | 274 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 144 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 231 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 13 | $3K |
| 83735 | <1% | 438 | $3K | |
| 87070 | <1% | 339 | $3K | |
| 84484 | <1% | 231 | $3K | |
| 87480 | <1% | 92 | $3K | |
| 87081 | <1% | 348 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 68 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 178 | $2K |
| 85027 | <1% | 326 | $2K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 25 | $2K |
| 80061 | Lipid panel | <1% | 289 | $2K |
| 86592 | <1% | 75 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 153 | $2K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 14 | $2K |
| 87510 | <1% | 92 | $2K | |
| 81001 | <1% | 549 | $2K | |
| 87660 | <1% | 92 | $2K | |
| 81025 | <1% | 226 | $1K | |
| 82553 | <1% | 119 | $1K | |
| 80074 | <1% | 49 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 23 | $1K |
| 73630 | <1% | 62 | $1K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 448 | $1K |
| 87205 | <1% | 233 | $1K | |
| 83690 | <1% | 151 | $985.00 | |
| 86850 | <1% | 65 | $964.19 | |
| 80076 | <1% | 168 | $789.64 | |
| 82728 | <1% | 50 | $772.66 | |
| 87186 | <1% | 93 | $724.64 | |
| 84439 | <1% | 80 | $675.29 | |
| 82150 | <1% | 96 | $639.47 | |
| 73610 | <1% | 30 | $604.87 | |
| 73562 | <1% | 26 | $604.87 | |
| 81003 | <1% | 265 | $568.22 | |
| 83655 | <1% | 28 | $563.56 | |
| 82948 | <1% | 92 | $482.01 | |
| 87400 | <1% | 18 | $393.84 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 13 | $346.60 |
| 87147 | <1% | 45 | $324.24 | |
| 83540 | <1% | 40 | $277.81 | |
| 86900 | <1% | 79 | $274.47 | |
| 86901 | <1% | 79 | $226.94 | |
| 73110 | <1% | 13 | $201.63 | |
| 82550 | <1% | 243 | $182.29 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12 | $156.80 |
| 85652 | <1% | 53 | $152.54 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 60 | $138.00 |
| 85610 | <1% | 30 | $115.43 | |
| 83550 | <1% | 14 | $103.61 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 169 | $47.30 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 182 | $47.30 |
| 82947 | <1% | 16 | $25.06 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 72 | $0.00 |
| 84460 | 0% | 12 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 115 | $0.00 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 344 | $0.00 |
| 80320 | 0% | 275 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 257 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 114 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 15 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWHIPPLE, CHARLES (GENERAL COUNSEL)
| Provider | Location | Paid |
|---|---|---|
| Hallmark Health System INC | Medford, MA | $1.79M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.